This antibody was purified from hybridoma (clone BTG-2G) supernatant using protein G agarose. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Wister rat splenocyte immunized with mouse IL-2Ralpha-transgenic mouse splenocyte.
Target:
CAMPATH-1/CD52
Application Dilute:
FCM: 20 ug/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted